Differentiating human pluripotent stem cells into vascular smooth muscle cells in three dimensional thermoreversible hydrogels
- PMID: 30483691
- DOI: 10.1039/c8bm01128a
Differentiating human pluripotent stem cells into vascular smooth muscle cells in three dimensional thermoreversible hydrogels
Abstract
Vascular smooth muscle cells (VSMCs) are of great value and are needed in large quantities for tissue engineering, drug screening, disease modeling and cell-based therapies. However, getting high quantity VSMCs remains a challenge. Here, we report a method for the scalable manufacturing of VSMCs from human pluripotent stem cells (hPSCs). hPSCs are expanded and differentiated into VSMCs in a three dimensional (3D) thermoreversible hydrogel. The hydrogel not only acts as a 3D scaffold for cells to grow, but also protects cells from hydrodynamic stresses in the culture vessel and prevents cells from excessive aggregation. Together, the hydrogel creates a cell-friendly microenvironment, leading to high culture efficiency. We show that VSMCs can be generated in 10 days with high viability (>90%), high purity (>80%) and high yield (∼2.0 × 107 cells per mL hydrogel) in the hydrogel scaffold. The generated VSMCs have normal functions. Genome-wide gene expression analysis shows VSMCs made in the hydrogel (i.e. 3D-VSMCs) have higher expression of genes related to vasculature development and glycolysis compared to VSMCs made in the conventional 2D cultures (i.e. 2D-VSMCs), while 2D-VSMCs have higher expression of genes related to cell proliferation. This simple, defined and efficient method is scalable for manufacturing hPSC-VSMCs for various biomedical applications.
Similar articles
-
Engineered Microenvironment for Manufacturing Human Pluripotent Stem Cell-Derived Vascular Smooth Muscle Cells.Stem Cell Reports. 2019 Jan 8;12(1):84-97. doi: 10.1016/j.stemcr.2018.11.009. Epub 2018 Dec 6. Stem Cell Reports. 2019. PMID: 30527760 Free PMC article.
-
Manufacturing human pluripotent stem cell derived endothelial cells in scalable and cell-friendly microenvironments.Biomater Sci. 2018 Dec 18;7(1):373-388. doi: 10.1039/c8bm01095a. Biomater Sci. 2018. PMID: 30484784
-
A Scalable and Efficient Bioprocess for Manufacturing Human Pluripotent Stem Cell-Derived Endothelial Cells.Stem Cell Reports. 2018 Aug 14;11(2):454-469. doi: 10.1016/j.stemcr.2018.07.001. Epub 2018 Aug 2. Stem Cell Reports. 2018. PMID: 30078557 Free PMC article.
-
Generation of Vascular Smooth Muscle Cells From Induced Pluripotent Stem Cells: Methods, Applications, and Considerations.Circ Res. 2021 Mar 5;128(5):670-686. doi: 10.1161/CIRCRESAHA.120.318049. Epub 2021 Mar 4. Circ Res. 2021. PMID: 33818124 Free PMC article. Review.
-
Deriving vascular smooth muscle cells from mesenchymal stromal cells: Evolving differentiation strategies and current understanding of their mechanisms.Biomaterials. 2017 Nov;145:9-22. doi: 10.1016/j.biomaterials.2017.08.028. Epub 2017 Aug 15. Biomaterials. 2017. PMID: 28843066 Review.
Cited by
-
Expression Profile of New Marker Genes Involved in Differentiation of Canine Adipose-Derived Stem Cells into Osteoblasts.Int J Mol Sci. 2021 Jun 22;22(13):6663. doi: 10.3390/ijms22136663. Int J Mol Sci. 2021. PMID: 34206369 Free PMC article.
-
Identification of RNA-based cell-type markers for stem-cell manufacturing systems with a statistical scoring function.Gene Rep. 2024 Mar;34:101869. doi: 10.1016/j.genrep.2023.101869. Epub 2023 Dec 12. Gene Rep. 2024. PMID: 38351912 Free PMC article.
-
Fabricating 3-dimensional human brown adipose microtissues for transplantation studies.Bioact Mater. 2022 Oct 27;22:518-534. doi: 10.1016/j.bioactmat.2022.10.022. eCollection 2023 Apr. Bioact Mater. 2022. PMID: 36330162 Free PMC article.
-
Concise Review: Harnessing iPSC-derived Cells for Ischemic Heart Disease Treatment.J Transl Int Med. 2020 May 9;8(1):20-25. doi: 10.2478/jtim-2020-0004. eCollection 2020 Mar. J Transl Int Med. 2020. PMID: 32435608 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources